Bystander LECT2 amyloidosis in tumor nephrectomy

CEN Case Rep. 2023 Feb;12(1):104-109. doi: 10.1007/s13730-022-00728-9. Epub 2022 Aug 20.

Abstract

Pathologic evaluation of the non-neoplastic renal parenchyma in tumor nephrectomy specimens is critical and can detect both renal-limited and systemic pathologies. We report the case of a 69-year-old Punjabi male who underwent cytoreductive nephrectomy for advanced renal cell carcinoma after immunotherapy. We detected clinically unexpected leukocyte chemotactic factor 2 (LECT2) amyloidosis during pathologic analysis of the surrounding non-neoplastic renal parenchyma, which was confirmed by mass spectrometry. LECT2 amyloidosis occurs predominantly in Hispanic patients and has only rarely been described in Punjabi patients. This case highlights the importance of careful pathologic evaluation of the non-neoplastic renal parenchyma of nephrectomy specimens and raises awareness that LECT2 amyloidosis can occur outside of the typical demographic of Hispanic patients.

Keywords: Amyloidosis; LECT2; Nephrectomy; Onconephrology; Punjabi; Renal cell carcinoma; Renal pathology.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amyloidosis* / diagnosis
  • Amyloidosis* / pathology
  • Carcinoma, Renal Cell* / diagnosis
  • Carcinoma, Renal Cell* / pathology
  • Carcinoma, Renal Cell* / surgery
  • Humans
  • Intercellular Signaling Peptides and Proteins / analysis
  • Kidney / pathology
  • Kidney Neoplasms* / diagnosis
  • Kidney Neoplasms* / pathology
  • Kidney Neoplasms* / surgery
  • Male
  • Nephrectomy

Substances

  • LECT2 protein, human
  • Intercellular Signaling Peptides and Proteins